| Literature DB >> 29891116 |
Mohammadamin Sadeghi1, Mahsa Keshavarz-Fathi2, Vickie Baracos3, Jann Arends4, Maryam Mahmoudi5, Nima Rezaei6.
Abstract
Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life, responsiveness to chemotherapy, and survival in advanced cancer patients. Our understanding of cachexia has grown greatly in recent years and the roles of many tumor-derived and host-derived compounds have been elucidated as mediators of cancer cachexia. However, cancer cachexia remains an unmet medical need and attempts towards a standard treatment guideline have been unsuccessful. This review covers the diagnosis, assessment, and treatment of cancer cachexia; the elements impeding the formulation of a standard management guideline; and future directions of research for the improvement and standardization of current treatment procedures.Entities:
Keywords: Biomarker; Cancer cachexia; Exercise; Nutrition; Nutritional treatment; Palliative medicine; Pharmacologic treatment; Psychological treatment
Mesh:
Year: 2018 PMID: 29891116 DOI: 10.1016/j.critrevonc.2018.05.006
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN: 1040-8428 Impact factor: 6.312